Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol

Pregnancy, Ovarian Clinical Trial

Official title:
Clinical and Live Birth Rates After Controlled Ovarian Stimulation With the Long Antagonist Protocol Versus the Long Agonist Protocol

Status Recruiting

Clinical Trial Summary

A prospective study of the evaluation of the clinical IVF (in vitro fertilization) results after following Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus following Long Agonist protocol

Clinical Trial Description

A prospective study of the clinical results in women who followed the Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus women who followed Long Agonist protocol, in an In Vitro Fertilization (IVF) try. In particular, the Clinical Pregnancy Rates (CPR) and Live Birth Rates (LBR) were estimated for the two groups of patients. The number of the formed blastocysts was also measured in each group of patients. ;

Study Design

Related Conditions & MeSH terms

Pregnancy, Ovarian

Clinical Trial Details

NCT number	NCT03693534
Study type	Observational
Source	Assisting Nature
Contact	Evaggelos Papanikolaou, MD,PhD
Phone	00302310424294
Email	drvagpapanikolaou@yahoo.gr
Status	Recruiting
Phase
Start date	February 15, 2017
Completion date	June 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03463278` - The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate
Completed	`NCT02442895` - Biomarkers of Ovarian Reserve and Correlation With IVF Treatments	N/A
Completed	`NCT00773825` - Genomic Imprinting and Assisted Reproductive Technologies	N/A
Recruiting	`NCT03240159` - Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix	Phase 3
Recruiting	`NCT03684421` - Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol